These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27679422)

  • 1. The variability in beta-cell function in placebo-treated subjects with type 2 diabetes: application of the weight-HbA1c-insulin-glucose (WHIG) model.
    Duong JK; de Winter W; Choy S; Plock N; Naik H; Krauwinkel W; Visser SA; Verhamme KM; Sturkenboom MC; Stricker BH; Danhof M
    Br J Clin Pharmacol; 2017 Mar; 83(3):487-497. PubMed ID: 27679422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight-HbA1c-insulin-glucose model for describing disease progression of type 2 diabetes.
    Choy S; Kjellsson MC; Karlsson MO; de Winter W
    CPT Pharmacometrics Syst Pharmacol; 2016 Jan; 5(1):11-9. PubMed ID: 26844011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in insulin sensitivity and β-cell function following ileal interposition with sleeve gastrectomy in type 2 diabetic patients: potential mechanisms.
    De Paula AL; Stival AR; Halpern A; DePaula CC; Mari A; Muscelli E; Vencio S; Ferrannini E
    J Gastrointest Surg; 2011 Aug; 15(8):1344-53. PubMed ID: 21557013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying Type 2 Diabetes Mellitus.
    de Winter W; DeJongh J; Post T; Ploeger B; Urquhart R; Moules I; Eckland D; Danhof M
    J Pharmacokinet Pharmacodyn; 2006 Jun; 33(3):313-43. PubMed ID: 16552630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased circulating levels of oxytocin in obesity and newly diagnosed type 2 diabetic patients.
    Qian W; Zhu T; Tang B; Yu S; Hu H; Sun W; Pan R; Wang J; Wang D; Yang L; Mao C; Zhou L; Yuan G
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4683-9. PubMed ID: 25233153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired beta-cell sensitivity to glucose and maximal insulin secretory capacity in adolescents with type 2 diabetes.
    Elder DA; Woo JG; D'Alessio DA
    Pediatr Diabetes; 2010 Aug; 11(5):314-21. PubMed ID: 19961550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DPP-4 inhibitor treatment: β-cell response but not HbA
    Kozlovski P; Bhosekar V; Foley JE
    Vasc Health Risk Manag; 2017; 13():123-126. PubMed ID: 28408838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant medication use and trajectories of fasting plasma glucose, glycated haemoglobin, β-cell function and insulin sensitivity: a 9-year longitudinal study of the D.E.S.I.R. cohort.
    Azevedo Da Silva M; Dugravot A; Balkau B; Roussel R; Fumeron F; Elbaz A; Canonico M; Singh-Manoux A; Nabi H;
    Int J Epidemiol; 2015 Dec; 44(6):1927-40. PubMed ID: 26245205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
    Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion.
    Briatore L; Salani B; Andraghetti G; Danovaro C; Sferrazzo E; Scopinaro N; Adami GF; Maggi D; Cordera R
    Obesity (Silver Spring); 2008 Jan; 16(1):77-81. PubMed ID: 18223616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of β-cell functions with low-dose insulin therapy: study in newly diagnosed type 2 diabetes mellitus patients.
    Bhattacharya S; Ammini AC; Jyotsna V; Gupta N; Dwivedi S
    Diabetes Technol Ther; 2011 Apr; 13(4):461-5. PubMed ID: 21355720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lixisenatide as add-on treatment among patients with different β-cell function levels as assessed by HOMA-β index.
    Bonadonna RC; Blonde L; Antsiferov M; Berria R; Gourdy P; Hatunic M; Mohan V; Horowitz M
    Diabetes Metab Res Rev; 2017 Sep; 33(6):. PubMed ID: 28303626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum adropin levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass index.
    Zang H; Jiang F; Cheng X; Xu H; Hu X
    Endocr J; 2018 Jul; 65(7):685-691. PubMed ID: 29669965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
    da Silva RC; Miranda WL; Chacra AR; Dib SA
    J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic Retinopathy in Newly Diagnosed Subjects With Type 2 Diabetes Mellitus: Contribution of β-Cell Function.
    Roy Chowdhury S; Thomas RL; Dunseath GJ; Peter R; Rees DA; North RV; Luzio SD; Owens DR
    J Clin Endocrinol Metab; 2016 Feb; 101(2):572-80. PubMed ID: 26652932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais.
    Chailurkit LO; Jongjaroenprasert W; Chanprasertyothin S; Ongphiphadhanakul B
    J Clin Lab Anal; 2007; 21(2):85-90. PubMed ID: 17385686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel canine models of obese prediabetes and mild type 2 diabetes.
    Ionut V; Liu H; Mooradian V; Castro AV; Kabir M; Stefanovski D; Zheng D; Kirkman EL; Bergman RN
    Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E38-48. PubMed ID: 19843874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of serum omentin-1 levels in normal subjects, type 2 diabetes and type 2 diabetes with overweight and obesity in Chinese adults.
    Zhang Q; Zhu L; Zheng M; Fan C; Li Y; Zhang D; He Y; Yang H
    Ann Endocrinol (Paris); 2014 Jul; 75(3):171-5. PubMed ID: 24997770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
    Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.